Azeria Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Liquidation

  • Investors
  • 1

Azeria Therapeutics General Information

Description

Developer of small-molecule pipeline devices designed to aid in the treatment of breast and prostate cancer. The company's devices develop treatments for hormone-resistant breast cancer patients where there are significant areas of unmet clinical need to selectively inhibit pioneer factors, enabling healthcare organizations and medical professionals to treat multiple cancer types.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • CRUK Cambridge Institute
  • Robinson Way
  • Cambridge CB2 0RE
  • England, United Kingdom
+44 01223
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • CRUK Cambridge Institute
  • Robinson Way
  • Cambridge CB2 0RE
  • England, United Kingdom
+44 01223

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Azeria Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Liquidation 08-Dec-2020 Completed Bankruptcy: Liquidation
3. Early Stage VC (Series B) 21-Nov-2019 Completed Generating Revenue
2. Early Stage VC (Series A) 04-Sep-2018 $5.14M $5.14M Completed Generating Revenue
1. University Spin-Out 01-Jan-2017 Completed Generating Revenue
To view Azeria Therapeutics’s complete valuation and funding history, request access »

Azeria Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Azeria Therapeutics’s complete cap table history, request access »

Azeria Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of small-molecule pipeline devices designed to aid in the treatment of breast and prostate cancer. The company
Other Healthcare Technology Systems
Cambridge, United Kingdom
11 As of 2020

South San Francisco, CA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Azeria Therapeutics Competitors (16)

One of Azeria Therapeutics’s 16 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genentech Formerly VC-backed South San Francisco, CA
Volastra Venture Capital-Backed New York, NY
Ona Therapeutics Venture Capital-Backed Barcelona, Spain
Gesynta Pharma Venture Capital-Backed Stockholm, Sweden
Ability Pharma Private Equity-Backed Cerdanyola, Spain
You’re viewing 5 of 16 competitors. Get the full list »

Azeria Therapeutics Patents

Azeria Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201916968-D0 Means and method for treating cancer Inactive 21-Nov-2019
GB-201909228-D0 Screen for inhibitors Inactive 27-Jun-2019
WO-2020260899-A1 Screen for inhibitors Inactive 27-Jun-2019
GB-201905318-D0 Inhibitor compounds Inactive 15-Apr-2019
GB-201905328-D0 Inhibitor compounds Inactive 15-Apr-2019
To view Azeria Therapeutics’s complete patent history, request access »

Azeria Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Azeria Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of Cambridge University
To view Azeria Therapeutics’s complete investors history, request access »

Azeria Therapeutics FAQs

  • When was Azeria Therapeutics founded?

    Azeria Therapeutics was founded in 2017.

  • Where is Azeria Therapeutics headquartered?

    Azeria Therapeutics is headquartered in Cambridge, United Kingdom.

  • What is the size of Azeria Therapeutics?

    Azeria Therapeutics has 11 total employees.

  • What industry is Azeria Therapeutics in?

    Azeria Therapeutics’s primary industry is Other Healthcare Technology Systems.

  • Is Azeria Therapeutics a private or public company?

    Azeria Therapeutics is a Private company.

  • What is Azeria Therapeutics’s current revenue?

    The current revenue for Azeria Therapeutics is .

  • How much funding has Azeria Therapeutics raised over time?

    Azeria Therapeutics has raised $46.4M.

  • Who are Azeria Therapeutics’s investors?

    University of Cambridge has invested in Azeria Therapeutics.

  • Who are Azeria Therapeutics’s competitors?

    Genentech, Volastra, Ona Therapeutics, Gesynta Pharma, and Ability Pharma are some of the 16 competitors of Azeria Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process